Abstract Number: 423 • ACR/ARP Annual Meeting 2019
Patient Reported Outcomes over 2 Years in Psoriatic Arthritis Patients Initiating Treatment with 1st, 2nd or 3rd TNF Inhibitor in Routine Care – Was PRO Remission Achieved? Results from the EuroSpA Collaboration
Lykke Midtbøll Ørnbjerg1, Lennart Jacobsson 2, Anne Gitte Loft 3, Florenzo Iannone 4, Michael J. Nissen 5, Eirik Kristianslund 6, Herman Mann 7, Maria José Santos 8, Manuel Pombo-Suarez 9, Kari K. Eklund 10, Ziga Rotar 11, Bjorn Gudbjornsson 12, Mehmet Akif Öztürk 13, Catalin Codreanu 14, Marleen van de Sande 15, Johan Wallman 16, Ennio Giulio Favalli 17, Burkhard Moeller 18, Joe Sexton 19, Karel Pavelka 7, Elsa Vieira-Sousa 20, Carlos Sánchez-Piedra 21, Nina Trokovic 22, Matija Tomsic 23, Thorvardur J Love 24, Ayşe Cefle 25, Ruxandra IONESCU 26, Irene van der Horst-Bruinsma 15, Gareth Jones 27, Cecilie Heegaard Brahe 28, Merete Lund Hetland 1 and Mikkel Østergaard 29, 1DANBIO and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Rigshospitalet, Copenhagen, Denmark, 2Dept of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden,, Gothenburg, Sweden, 3Department of Rheumatology, Aarhus University Hospital., Aarhus, Denmark, 4Department of Emergency and Transplantation , Rheumatology Unit, University Hospital of Bari, Bari, Italy., Bari, Italy, 5University Hospital Geneva, Geneva, Switzerland, 6Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway., Oslo, Norway, 7Institute of Rheumatology, Department of Rheumatology, 1st Faculty of Medicine, Prague, Czech Republic, Prague 2, Czech Republic, 8Rheumatology department, Hospital Garcia de Orta, Almada, Portugal, 9Unit Research, Spanish Society of Rheumatology, Madrid, Spain, 10ROB-FIN registry, Department of Medicine, Helsinki University and University Hospital, Helsinki, Finland, 11UMC LJUBLJANA, DPT. OF RHEUMATOLOGY, LJUBLJANA, Slovenia, 12Centre for Rheumatology Research, Landspitali and Faculty of Medicine, University of Iceland, Reykjavik, Iceland, 13Division of Rheumatology, Gazi University School of Medicine, Ankara, Turkey, Ankara, Turkey, 14Center of Rheumatic Diseases, University of Medicine and Pharmacy, Bucharest, Romania., Bucharest, Romania, 15Amsterdam University Medical Center, Amsterdam, Netherlands, 16Department of Clinical Sciences Lund, Rheumatology Lund University, Lund, Sweden, 17University of Milan, Department of Rheumatology, ASST Gaetano Pini-CTO, Milan, Lombardia, Italy, 18University Hospital Bern, Bern, Switzerland, 19Diakonhjemmet Hospital, Dept. of Rheumatology, Oslo, Norway, 20Rheumatology and Metabolic Bone Diseases, Hospital de Santa Maria - Centro Hospitalar Lisboa Norte, EPE | Rheumatology Research Unit, Instituto de Medicina Molecular - Faculty of Medicine, University of Lisbon, Lisbon Academic Medical Centre, Lisbon, Portugal,, Lisbon, Portugal, 21Research Unit, Spanish Society of Rheumatology, Madrid, Spain, 22Helsinki University Central Hospital, Helsinki, Finland, 23Department of Rheumatology, University Medical Centre, Ljubjana, Slovenia, 24Faculty of Medicine, University of Iceland, Reykjavik, Iceland, 25Division of Rheumatology, Kocaeli University School of Medicine, Kocaeli, Turkey, Kocaeli, Turkey, 26SPITALUL CLINIC SFANTA MARIA, Bucharest, 27University of Aberdeen, Aberdeen, United Kingdom, 28Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet Glostrup, Denmark, Copenhagen, Denmark, 29Copenhagen Center for Arthritis Research, University of Copenhagen, Copenhagen, Denmark
Background/Purpose: Patient Reported Outcomes (PROs) provide important information on assessment of pain, disease activity, fatigue and physical function in patients with psoriatic arthritis (PsA). Knowledge…
Abstracts tagged "psoriatic arthritis and patient-reported outcome measures"
Abstract Number: 423 • ACR/ARP Annual Meeting 2019
Patient Reported Outcomes over 2 Years in Psoriatic Arthritis Patients Initiating Treatment with 1st, 2nd or 3rd TNF Inhibitor in Routine Care – Was PRO Remission Achieved? Results from the EuroSpA Collaboration
Background/Purpose: Patient Reported Outcomes (PROs) provide important information on assessment of pain, disease activity, fatigue and physical function in patients with psoriatic arthritis (PsA). Knowledge…
